Literature DB >> 8323635

Guidelines for estimating the real cost of an objective structured clinical examination.

R K Reznick1, S Smee, J S Baumber, R Cohen, A Rothman, D Blackmore, M Bérard.   

Abstract

A major impediment to the use of the objective structured clinical examination (OSCE) is that it is a labor-intensive and costly form of assessment. The cost of an OSCE is highly dependent on the particular model used, the extent to which hidden costs are reported, and the purpose of the examination. The authors detail hypothetical costs of running a four-hour OSCE for 120 medical students at one medical school. Costs are reported for four phases of this process: development, production, administration, and post-examination reporting and analysis. Costs are reported at two ends of the spectrum: the high end, where it is assumed that little is paid for by the institution and that faculty receive honoraria for work put into the examination; and the low end, where it is assumed that the sponsoring institution defrays basic costs and that faculty do not receive honoraria for their participation. The total costs reported for a first-time examination were $104,400 and $59,460 (Canadian dollars) at the high and low ends, respectively. These translate to per-student costs of $870 and $496. The cost of running an OSCE is high. However, the OSCE is uniquely capable of assessing many fundamental clinical skills that are presently not being assessed in a rigorous way in most medical schools.

Mesh:

Year:  1993        PMID: 8323635     DOI: 10.1097/00001888-199307000-00001

Source DB:  PubMed          Journal:  Acad Med        ISSN: 1040-2446            Impact factor:   6.893


  13 in total

1.  Assessment of surgical competence.

Authors:  A Darzi; S Mackay
Journal:  Qual Health Care       Date:  2001-12

2.  Significant transfer of surgical skills obtained with an advanced laparoscopic training program to a laparoscopic jejunojejunostomy in a live porcine model: feasibility of learning advanced laparoscopy in a general surgery residency.

Authors:  Julián Varas; Ricardo Mejía; Arnoldo Riquelme; Felipe Maluenda; Erwin Buckel; José Salinas; Jorge Martínez; Rajesh Aggarwal; Nicolás Jarufe; Camilo Boza
Journal:  Surg Endosc       Date:  2012-06-26       Impact factor: 4.584

3.  The assessment of professional competence: Developments, research and practical implications.

Authors:  C P Van Der Vleuten
Journal:  Adv Health Sci Educ Theory Pract       Date:  1996-01       Impact factor: 3.853

4.  The Part II examination.

Authors:  W D Dauphinee; D A Kendel
Journal:  CMAJ       Date:  1994-09-01       Impact factor: 8.262

Review 5.  Recent developments in assessing medical students.

Authors:  S L Fowell; J G Bligh
Journal:  Postgrad Med J       Date:  1998-01       Impact factor: 2.401

6.  Design and Evaluation of a New National Pharmacy Internship Program in Ireland.

Authors:  Judith Strawbridge; James Barlow; Aisling O'Leary; Muirne Spooner; Eric Clarke; Richard Arnett; Chris Langley; Keith Wilson; Paul Gallagher
Journal:  Am J Pharm Educ       Date:  2019-05       Impact factor: 2.047

7.  A computer vision technique for automated assessment of surgical performance using surgeons' console-feed videos.

Authors:  Amir Baghdadi; Ahmed A Hussein; Youssef Ahmed; Lora A Cavuoto; Khurshid A Guru
Journal:  Int J Comput Assist Radiol Surg       Date:  2018-11-20       Impact factor: 2.924

8.  Developing a Framework for Objective Structured Clinical Examinations Using the Nominal Group Technique.

Authors:  Safeera Y Hussainy; Matthew F Crum; Paul J White; Ian Larson; Daniel T Malone; David T Manallack; Joseph A Nicolazzo; Jennifer McDowell; Angelina S Lim; Carl M Kirkpatrick
Journal:  Am J Pharm Educ       Date:  2016-11-25       Impact factor: 2.047

9.  Making reaccreditation meaningful.

Authors:  F Nicol
Journal:  Br J Gen Pract       Date:  1995-06       Impact factor: 5.386

10.  Managing benign prostatic hyperplasia in primary care. Patient-centred approach.

Authors:  J McSherry; R Weiss
Journal:  Can Fam Physician       Date:  2000-02       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.